Cystic Fibrosis Medication - Genetic Mutations

Relevant Publications

Potential of pharmacogenetics in minimizing drug therapy problems in cystic fibrosis.

Issue Release: 2024

The cost of simplifying treatments for cystic fibrosis: Implications of the SIMPLIFY trial.

Issue Release: 2024

Necessity of Tobramycin trough Levels in Once Daily Iv-Treatment in Patients with Cystic Fibrosis.

Issue Release: 2024

Elevated Eosinophil Counts in Acute Exacerbations of Bronchiectasis: Unveiling a Distinct Clinical Phenotype.

Issue Release: 2024

The Impact of Cost of Living on the Quality of Life of Cystic Fibrosis Patients: A Study in Greece.

Issue Release: 2024

Refractory hypothyroidism in children: an overview.

Issue Release: 2024

[Self-care capacity of adult cystic fibrosis patients during transition/transfer between services].

Issue Release: 2024

Cystic Fibrosis Foundation Evidence-Based Guideline for the Management of CRMS/CFSPID.

Issue Release: 2024

Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor.

Issue Release: 2024

Seroprevalence of SARS-CoV-2 IgG in people with cystic fibrosis.

Issue Release: 2024

Evaluation of the efficiency of nanomicellar formulation of fat-soluble vitamins in patients with cystic fibrosis: the study protocol for a randomized controlled trial.

Issue Release: 2024

Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with Cystic Fibrosis following liver transplantation: A systematic review.

Issue Release: 2024

Gastrointestinal Pathologies in Pediatric Patients With Cystic Fibrosis Undergoing Endoscopy: A Single-Center Retrospective Review Over 15 Years.

Issue Release: 2024

Changes in exercise capacity in people with Cystic Fibrosis after one year of Elexacaftor/Tezacaftor/Ivacaftor treatment - A Danish prospective cohort.

Issue Release: 2024

Bronchodilator response assessment through impulse oscillometry system and spirometry in children and adolescents with cystic fibrosis.

Issue Release: 2024

Prevalence of psychotropic medication dispensing to people living with cystic fibrosis in Australia: 2013-2022.

Issue Release: 2024

Cystic fibrosis patient characteristics and healthcare resource utilization in Finland using linked registries.

Issue Release: 2024

Diagnosis and treatment of ADHD in pediatric patients during the first year of elexacaftor/tezacaftor/ivacaftor.

Issue Release: 2024

Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of lung disease.

Issue Release: 2024

[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].

Issue Release: 2024

What is Immunotherapy?

What is the Genetic Advantage of Sickle Cell Trait?

What is Gene Therapy?

Where Do Neutral Mutations Typically Occur?

How Does Substitution Occur?

How do TALENs work?

How Are Mutagens Detected?

How Do CFTR Gene Mutations Cause Disease?

Why are Induced Mutations Important in Research?

What Are the Applications of Studying Nucleotide Mutations?

Relevant Topics